Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.43 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.43 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7605944 | 0.87 | TSHR (0.53) | TSHRHSD17B10PPARGPPARAKDM4E | |
| SCHEMBL14273071 | 0.87 | PTGDR2 (0.51) | TSHRPPARGPPARAKDM4EKMT2A | |
| SCHEMBL4005109 | 0.87 | FOLH1 (0.52) | TSHRHSD17B10PPARGPPARAKDM4E | |
| SCHEMBL3225523 | 0.87 | TSHR (0.51) | TSHRHSD17B10PPARGPPARAKDM4E | |
| SCHEMBL27761412 | 0.87 | PPARA (0.58) | PPARGPPARAKDM4EKMT2A | |
| SCHEMBL8471711 | 0.86 | KMT2A (0.60) | TSHRHSD17B10KDM4EKMT2ALMNA | |
| SCHEMBL28032082 | 0.86 | PPARA (0.53) | TSHRHSD17B10PPARGPPARAKDM4E | |
| Hydrochloric Acid SCHEMBL8574910 | 0.85 | TSHR (0.47) | TSHRHSD17B10PPARGPPARAKDM4E | |
| SCHEMBL7802422 | 0.85 | TDP1 (0.64) | TSHRHSD17B10KDM4ECYP3A4KMT2A | |
| SCHEMBL8650713 | 0.84 | PPARA (0.51) | TSHRHSD17B10PPARGPPARAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023121411-A1 | ECO-FRIENDLY METHOD FOR DECOLORIZATION AND DEPOLYMERIZATION OF COLORED POLYMER CONTAINING ESTER FUNCTIONAL GROUP | 한국화학연구원 | 2023-06-29 | — | — | WO | claimed |
| EP-0431626-B1 | Process for reducing polymer build-up in heat exchangers during polymerization of alpha-olefins | UNION CARBIDE CHEM PLASTIC (US) | 1995-04-19 | — | — | EP | claimed |
| US-5037905-A | Process for reducing polymer build-up in heat exchangers during polymerization of alpha-olefins | UNION CARBIDE CHEMICALS AND PLASTICS TECHNOLOGY CORPORATION (US) | 1991-08-06 | — | — | US | claimed |
| EP-0431626-A1 | Process for reducing polymer build-up in heat exchangers during polymerization of alpha-olefins | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1991-06-12 | — | — | EP | claimed |
| WO-2023121411-A1 | ECO-FRIENDLY METHOD FOR DECOLORIZATION AND DEPOLYMERIZATION OF COLORED POLYMER CONTAINING ESTER FUNCTIONAL GROUP | 한국화학연구원 | 2023-06-29 | — | — | WO | disclosed |
| US-10358509-B2 | Continuous gas-phase polymerization processes | BASELL POLYOLEFINE GMBH (DE) | 2019-07-23 | — | — | US | disclosed |
| EP-3137516-B1 | CONTINUOUS GAS-PHASE POLYMERIZATION PROCESSES | BASELL POLYOLEFINE GMBH (DE) | 2018-04-25 | — | — | EP | disclosed |
| US-20180079842-A1 | CONTINUOUS GAS-PHASE POLYMERIZATION PROCESSES | BASELL POLYOLEFINE GMBH (DE) | 2018-03-22 | — | — | US | disclosed |
| EP-1547614-B1 | MEDICINAL COMPOSITION FOR INHIBITING THE EXPRESSION OF ATP-CITRATE LYASE AND USE THEREOF | AJINOMOTO KK (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20090176835-A1 | PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THE EXPRESSION OF ATP CITRATE LYASE AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-0935614-B1 | PROCESS FOR REDUCING POLYMER BUILD-UP IN RECYCLE LINES AND HEAT EXCHANGERS DURING POLYMERIZATIONS ENPLOYING BUTADIENE, ISOPRENE, AND/OR STYRENE | UNION CARBIDE CHEM PLASTIC (US) | 2001-12-05 | — | — | EP | disclosed |
| US-20010025045-A1 | Substituted isoquinoline derivatives and their use as anticonvulsants | SMITHKLINE BEECHAM P.L.C. | 2001-09-27 | — | — | US | disclosed |
| EP-0251100-B1 | IMPROVING CATALYST PRODUCTIVITY IN THE POLYMERIZATION OF OLEFINS | UNION CARBIDE CORPORATION (US) | 1993-06-16 | — | — | EP | disclosed |
| US-5200502-A | Contacting with 1,2-diether organic compound; controlling activity | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-04-06 | — | — | US | disclosed |
| US-5037905-A | Process for reducing polymer build-up in heat exchangers during polymerization of alpha-olefins | UNION CARBIDE CHEMICALS AND PLASTICS TECHNOLOGY CORPORATION (US) | 1991-08-06 | — | — | US | disclosed |
| US-5037905-A | Process for reducing polymer build-up in heat exchangers during polymerization of alpha-olefins | UNION CARBIDE CHEMICALS AND PLASTICS TECHNOLOGY CORPORATION (US) | 1991-08-06 | — | — | US | disclosed |
| EP-0431626-A1 | Process for reducing polymer build-up in heat exchangers during polymerization of alpha-olefins | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1991-06-12 | — | — | EP | disclosed |
| EP-0431626-A1 | Process for reducing polymer build-up in heat exchangers during polymerization of alpha-olefins | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1991-06-12 | — | — | EP | disclosed |
| US-4981929-A | CATALYST SELECTIVITY, COORDINATION CATALYSTS | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1991-01-01 | — | — | US | disclosed |
| EP-0251100-A2 | Improving catalyst productivity in the polymerization of olefins | UNION CARBIDE CORPORATION (US) | 1988-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176835-A1 | PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THE EXPRESSION OF ATP CITRATE LYASE AND USE THEREOF | ACLY, CS, GLS2 | TSHR 1308/4885HSD17B10 317/4885PPARG 151/4885 |
| US-20010025045-A1 | Substituted isoquinoline derivatives and their use as anticonvulsants | INA, GRIN2C, GRIN2A | TSHR 4289/4885HSD17B10 1492/4885PPARG 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.